{"transactions":[{"id":703088,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-27T20:10:07.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":360000,"derivative":{"exercise_price":22.01,"expiration_date":"2036-07-22","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001167496-26-000005","document":"form4-07272026_040701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749626000005/form4-07272026_040701.xml","form_type":"4"}},{"id":703087,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-27T20:10:07.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's common stock (\"Common Stock\") underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":870704,"source":{"system":"sec-edgar","filing":"0001167496-26-000005","document":"form4-07272026_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749626000005/form4-07272026_040701.xml","form_type":"4"}},{"id":742044,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T21:00:03.000Z","date":"2026-06-09","kind":"purchase","planned":false,"acquired":true,"shares":62500,"price":4,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock purchased in connection with the Issuer's underwritten offering, which closed on June 11, 2026."}],"balance_after":318608,"source":{"system":"sec-edgar","filing":"0001193125-26-267836","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000119312526267836/ownership.xml","form_type":"4"}},{"id":755407,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:00:05.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 81,000 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":81000,"derivative":{"exercise_price":5.95,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0001193125-26-254123","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000119312526254123/ownership.xml","form_type":"4"}},{"id":762285,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2026-05-27T10:05:29.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":false,"shares":128054,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 4, 2025, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer in a private placement, which closed on August 25, 2025, issued and sold to the Reporting Person 128,054 shares of the Issuer's common stock and accompanying warrants (the \"Warrants\") to purchase up to an aggregate of 128,054 shares of the Issuer's common stock at a combined price per share and accompanying Warrant of $0.8677."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Warrants are exercisable at any time on or after the original issuance date until the 30th day following the date on which the data from the single ascending dose and multiple ascending dose portions of the Issuer's Phase 1 clinical trial of SL-325, including receptor occupancy and safety data, and the design of the planned Phase 2 clinical trial(s) have been announced publicly."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Warrants are exercisable at any time on or after the original issuance date until the 30th day following the date on which the data from the single ascending dose and multiple ascending dose portions of the Issuer's Phase 1 clinical trial of SL-325, including receptor occupancy and safety data, and the design of the planned Phase 2 clinical trial(s) have been announced publicly."}],"balance_after":0,"derivative":{"exercise_price":1.0846,"underlying":"Common Stock","underlying_shares":128054},"source":{"system":"sec-edgar","filing":"0001193125-26-240347","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000119312526240347/ownership.xml","form_type":"4"}},{"id":762284,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-27T10:05:29.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":128054,"price":1.0846,"value":138887.3684,"ownership":{"direct":true},"balance_after":256108,"source":{"system":"sec-edgar","filing":"0001193125-26-240347","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000119312526240347/ownership.xml","form_type":"4"}},{"id":824444,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-31T11:11:39.000Z","date":"2026-03-27","kind":"purchase","planned":false,"acquired":true,"shares":25450,"price":19.67,"value":500601.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction report was $19.67, and the range of prices were between $19.63 and $19.70, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":690704,"source":{"system":"sec-edgar","filing":"0001167496-26-000003","document":"form4-03312026_110335.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749626000003/form4-03312026_110335.xml","form_type":"4"}},{"id":957403,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-30T23:47:24.000Z","date":"2025-12-30","kind":"purchase","planned":false,"acquired":true,"shares":4729,"price":21.15,"value":100018.35,"ownership":{"direct":true},"balance_after":665254,"source":{"system":"sec-edgar","filing":"0001167496-25-000010","document":"form4-12302025_111219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749625000010/form4-12302025_111219.xml","form_type":"4"}},{"id":961332,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-22T12:38:54.000Z","date":"2025-12-19","kind":"gift","planned":false,"acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person gifted the shares of the Issuer's common stock to the Clay B. Siegall 2025 Grantor Retained Annuity Trust, of which the Reporting Person's brother is the trustee and the Reporting Person's children are the beneficiaries. The Reporting Person does not have or share investment control over these shares."},{"field":"shares","element":"transactionShares","label":"F3","text":"The shares are subject to a lockup agreement entered into by the Reporting Person on December 15, 2025 (the \"Lock-Up Agreement\"). The transferee has agreed to be bound by the terms of the Lock-Up Agreement."}],"balance_after":660525,"source":{"system":"sec-edgar","filing":"0001167496-25-000008","document":"form4-12222025_121251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749625000008/form4-12222025_121251.xml","form_type":"4"}},{"id":961331,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-22T12:38:54.000Z","date":"2025-12-19","kind":"purchase","planned":false,"acquired":true,"shares":7278,"price":20.48,"value":149053.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction report was $20.48, and the range of prices were between $20.36 and $20.50, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":860525,"source":{"system":"sec-edgar","filing":"0001167496-25-000008","document":"form4-12222025_121251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749625000008/form4-12222025_121251.xml","form_type":"4"}},{"id":963433,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-18T22:03:54.000Z","date":"2025-12-18","kind":"purchase","planned":false,"acquired":true,"shares":46511,"price":21.5,"value":999986.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person purchased the shares in connection with the Issuer's recently completed underwritten public offering of common stock."}],"balance_after":853247,"source":{"system":"sec-edgar","filing":"0001167496-25-000006","document":"form4-12182025_101250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749625000006/form4-12182025_101250.xml","form_type":"4"}},{"id":1012731,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-10-28T22:30:25.000Z","date":"2025-10-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16800,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 8, 2025, by and among Issuer, Novartis AG, a company limited by shares (Aktiengesellschaft) incorporated under the laws of Switzerland (\"Parent\"), and Torino Merger Sub Inc., a Delaware corporation and indirect wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, on October 28, 2025, Merger Sub completed a cash tender offer to acquire all of the shares of common stock of the Issuer, par value $0.0001 (the \"Shares\"), issued and outstanding immediately prior to the effective time of the merger (the \"Effective Time\"), in exchange for $48.00 in cash per Share, subject to any applicable withholding of taxes (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each stock option that was outstanding and unexercised immediately prior to the Effective Time was automatically canceled and terminated and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares issuable upon exercise of such option or portion thereof, subject to any applicable withholding of taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each stock option that was outstanding and unexercised immediately prior to the Effective Time was automatically canceled and terminated and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares issuable upon exercise of such option or portion thereof, subject to any applicable withholding of taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each stock option that was outstanding and unexercised immediately prior to the Effective Time was automatically canceled and terminated and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares issuable upon exercise of such option or portion thereof, subject to any applicable withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":18.73,"underlying":"Common Stock","underlying_shares":16800},"source":{"system":"sec-edgar","filing":"0001167496-25-000005","document":"form4-10282025_061021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749625000005/form4-10282025_061021.xml","form_type":"4"}},{"id":1012730,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-10-28T22:30:25.000Z","date":"2025-10-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 8, 2025, by and among Issuer, Novartis AG, a company limited by shares (Aktiengesellschaft) incorporated under the laws of Switzerland (\"Parent\"), and Torino Merger Sub Inc., a Delaware corporation and indirect wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, on October 28, 2025, Merger Sub completed a cash tender offer to acquire all of the shares of common stock of the Issuer, par value $0.0001 (the \"Shares\"), issued and outstanding immediately prior to the effective time of the merger (the \"Effective Time\"), in exchange for $48.00 in cash per Share, subject to any applicable withholding of taxes (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each stock option that was outstanding and unexercised immediately prior to the Effective Time was automatically canceled and terminated and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares issuable upon exercise of such option or portion thereof, subject to any applicable withholding of taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each stock option that was outstanding and unexercised immediately prior to the Effective Time was automatically canceled and terminated and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares issuable upon exercise of such option or portion thereof, subject to any applicable withholding of taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each stock option that was outstanding and unexercised immediately prior to the Effective Time was automatically canceled and terminated and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares issuable upon exercise of such option or portion thereof, subject to any applicable withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":13.91,"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001167496-25-000005","document":"form4-10282025_061021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749625000005/form4-10282025_061021.xml","form_type":"4"}},{"id":1012729,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-10-28T22:30:25.000Z","date":"2025-10-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 8, 2025, by and among Issuer, Novartis AG, a company limited by shares (Aktiengesellschaft) incorporated under the laws of Switzerland (\"Parent\"), and Torino Merger Sub Inc., a Delaware corporation and indirect wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, on October 28, 2025, Merger Sub completed a cash tender offer to acquire all of the shares of common stock of the Issuer, par value $0.0001 (the \"Shares\"), issued and outstanding immediately prior to the effective time of the merger (the \"Effective Time\"), in exchange for $48.00 in cash per Share, subject to any applicable withholding of taxes (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each stock option that was outstanding and unexercised immediately prior to the Effective Time was automatically canceled and terminated and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares issuable upon exercise of such option or portion thereof, subject to any applicable withholding of taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each stock option that was outstanding and unexercised immediately prior to the Effective Time was automatically canceled and terminated and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares issuable upon exercise of such option or portion thereof, subject to any applicable withholding of taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each stock option that was outstanding and unexercised immediately prior to the Effective Time was automatically canceled and terminated and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares issuable upon exercise of such option or portion thereof, subject to any applicable withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":18.55,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001167496-25-000005","document":"form4-10282025_061021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749625000005/form4-10282025_061021.xml","form_type":"4"}},{"id":1054758,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2025-08-27T10:30:05.000Z","date":"2025-08-25","kind":"grant","planned":false,"acquired":true,"shares":128054,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 4, 2025, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer in a private placement, which closed on August 25, 2025, issued and sold to the Reporting Person 128,054 shares of the Issuer's common stock and accompanying warrants (the \"Warrants\") to purchase up to an aggregate of 128,054 shares of the Issuer's common stock at a combined price per share and accompanying Warrant of $0.8677."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 4, 2025, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer in a private placement, which closed on August 25, 2025, issued and sold to the Reporting Person 128,054 shares of the Issuer's common stock and accompanying warrants (the \"Warrants\") to purchase up to an aggregate of 128,054 shares of the Issuer's common stock at a combined price per share and accompanying Warrant of $0.8677."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Warrants are exercisable at any time on or after the original issuance date until the 30th day following the date on which the data from the single ascending dose and multiple ascending dose portions of the Issuer's Phase 1 clinical trial of SL-325, including receptor occupancy and safety data, and the design of the planned Phase 2 clinical trial(s) have been announced publicly."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Warrants are exercisable at any time on or after the original issuance date until the 30th day following the date on which the data from the single ascending dose and multiple ascending dose portions of the Issuer's Phase 1 clinical trial of SL-325, including receptor occupancy and safety data, and the design of the planned Phase 2 clinical trial(s) have been announced publicly."}],"balance_after":128054,"derivative":{"exercise_price":1.0846,"underlying":"Common Stock","underlying_shares":128054},"source":{"system":"sec-edgar","filing":"0001193125-25-189085","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000119312525189085/ownership.xml","form_type":"4"}},{"id":1054757,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-27T10:30:05.000Z","date":"2025-08-25","kind":"grant","planned":false,"acquired":true,"shares":128054,"price":0.8677,"value":111112.4558,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 4, 2025, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer in a private placement, which closed on August 25, 2025, issued and sold to the Reporting Person 128,054 shares of the Issuer's common stock and accompanying warrants (the \"Warrants\") to purchase up to an aggregate of 128,054 shares of the Issuer's common stock at a combined price per share and accompanying Warrant of $0.8677."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 4, 2025, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer in a private placement, which closed on August 25, 2025, issued and sold to the Reporting Person 128,054 shares of the Issuer's common stock and accompanying warrants (the \"Warrants\") to purchase up to an aggregate of 128,054 shares of the Issuer's common stock at a combined price per share and accompanying Warrant of $0.8677."}],"balance_after":128054,"source":{"system":"sec-edgar","filing":"0001193125-25-189085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000119312525189085/ownership.xml","form_type":"4"}},{"id":1078523,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-31T22:51:09.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":800000,"derivative":{"exercise_price":10.6,"expiration_date":"2035-07-28","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001415889-25-020782","document":"form4-07312025_100706.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000141588925020782/form4-07312025_100706.xml","form_type":"4"}},{"id":1086776,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-16T20:28:22.000Z","date":"2025-07-14","kind":"grant","planned":false,"acquired":true,"shares":33150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 33,150 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":33150,"derivative":{"exercise_price":0.82,"expiration_date":"2035-07-14","underlying":"Common Stock","underlying_shares":33150},"source":{"system":"sec-edgar","filing":"0000950170-25-096284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000095017025096284/ownership.xml","form_type":"4"}},{"id":1120063,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:33:54.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":16800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option vest on the earlier of the anniversary of the Transaction Date or the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":16800,"derivative":{"exercise_price":18.73,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":16800},"source":{"system":"sec-edgar","filing":"0001827506-25-000078","document":"wk-form4_1749242015.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000182750625000078/wk-form4_1749242015.xml","form_type":"4"}},{"id":1191157,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-26T20:03:00.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":137100,"price":7.29,"value":999459.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction report was $7.29, and the range of prices were between $7.16 and $7.40, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":806736,"source":{"system":"sec-edgar","filing":"0001415889-25-009017","document":"form4-03262025_080357.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000141588925009017/form4-03262025_080357.xml","form_type":"4"}},{"id":1287686,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-04T02:01:44.000Z","date":"2025-01-31","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":7.75,"value":1162500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person purchased the shares in connection with the Issuer's recently completed underwritten public offering of common stock."}],"balance_after":669636,"source":{"system":"sec-edgar","filing":"0001415889-25-002824","document":"form4-02042025_020240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000141588925002824/form4-02042025_020240.xml","form_type":"4"}},{"id":1353014,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-11-25T13:41:00.000Z","date":"2024-11-22","kind":"purchase","planned":false,"acquired":true,"shares":33943,"price":9.7787,"value":331918.4141,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average purchase price for the transaction report was $9.7787, and the range of prices were between $9.41 and $9.90. Upon request be the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":519636,"source":{"system":"sec-edgar","filing":"0001415889-24-027601","document":"form4-11252024_011157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000141588924027601/form4-11252024_011157.xml","form_type":"4"}},{"id":1353013,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-11-25T13:41:00.000Z","date":"2024-11-21","kind":"purchase","planned":false,"acquired":true,"shares":66057,"price":9.5412,"value":630263.0484,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction report was $9.5412, and the range of prices were between $9.41 and 9.68. Upon request be the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":485693,"source":{"system":"sec-edgar","filing":"0001415889-24-027601","document":"form4-11252024_011157.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000141588924027601/form4-11252024_011157.xml","form_type":"4"}},{"id":1435084,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock option (right to buy)","published_at":"2024-08-13T21:56:14.000Z","date":"2024-08-09","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on August 9, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":800000,"derivative":{"exercise_price":12.92,"expiration_date":"2034-08-08","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001415889-24-021240","document":"form4-08132024_090811.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000141588924021240/form4-08132024_090811.xml","form_type":"4"}},{"id":1472336,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T22:12:46.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":27700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 27,700 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":27700,"derivative":{"exercise_price":4.37,"expiration_date":"2034-06-21","underlying":"Common Stock","underlying_shares":27700},"source":{"system":"sec-edgar","filing":"0000950170-24-076398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000095017024076398/ownership.xml","form_type":"4"}},{"id":1487262,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:03:21.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option vest on the earlier of the anniversary of the Transaction Date or the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":13.91,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001827506-24-000056","document":"wk-form4_1717790594.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000182750624000056/wk-form4_1717790594.xml","form_type":"4"}},{"id":1507433,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-21T20:13:38.000Z","date":"2024-05-21","kind":"purchase","planned":false,"acquired":true,"shares":20434,"price":13.7784,"value":281547.8256,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average purchase price for the transaction report was $13.7784, and the range of prices were between $13.62 and $13.99. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":419636,"source":{"system":"sec-edgar","filing":"0001415889-24-013935","document":"form4-05212024_080525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000141588924013935/form4-05212024_080525.xml","form_type":"4"}},{"id":1507432,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-21T20:13:38.000Z","date":"2024-05-20","kind":"purchase","planned":false,"acquired":true,"shares":79566,"price":13.907,"value":1106524.362,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction report was $13.907,and the range of prices were between $13.77 and $13.99. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":399202,"source":{"system":"sec-edgar","filing":"0001415889-24-013935","document":"form4-05212024_080525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000141588924013935/form4-05212024_080525.xml","form_type":"4"}},{"id":1587281,"issuer":{"id":5224,"kind":"organization","name":"Shattuck Labs, Inc."},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-08T22:38:13.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":33409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase a total of 33,409 shares of the Issuer's common stock, and vests in three equal annual installments on each of the first three anniversaries of March 1, 2024, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":33409,"derivative":{"exercise_price":9.47,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":33409},"source":{"system":"sec-edgar","filing":"0000950170-24-028808","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000095017024028808/ownership.xml","form_type":"4"}},{"id":1709637,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-15T21:23:26.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest and become exercisable in thirty-six (36) equal monthly installments beginning on January 13, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":18.55,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-058774","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000120919123058774/doc4.xml","form_type":"4"}},{"id":1765690,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-10-04T21:35:48.000Z","date":"2023-10-02","kind":"purchase","planned":false,"acquired":true,"shares":169204,"price":5.91,"value":999995.64,"ownership":{"direct":true},"balance_after":319636,"source":{"system":"sec-edgar","filing":"0001209191-23-052053","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000120919123052053/doc4.xml","form_type":"4"}},{"id":2272482,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-05-13T19:13:16.000Z","date":"2022-05-12","kind":"exercise","acquired":false,"shares":10593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":51129,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":10593},"source":{"system":"sec-edgar","filing":"0001203311-22-000035","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000035/edgardoc.xml","form_type":"4"}},{"id":2272481,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-05-13T19:13:16.000Z","date":"2022-05-12","kind":"exercise","acquired":false,"shares":6450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":61722,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":6450},"source":{"system":"sec-edgar","filing":"0001203311-22-000035","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000035/edgardoc.xml","form_type":"4"}},{"id":2272480,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-05-13T19:13:16.000Z","date":"2022-05-12","kind":"sale","acquired":false,"shares":10593,"price":125.39,"value":1328256.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $125.00 to $125.99. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":666060,"source":{"system":"sec-edgar","filing":"0001203311-22-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000035/edgardoc.xml","form_type":"4"}},{"id":2272479,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-05-13T19:13:16.000Z","date":"2022-05-12","kind":"exercise","acquired":true,"shares":10593,"price":26.1,"value":276477.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":676653,"source":{"system":"sec-edgar","filing":"0001203311-22-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000035/edgardoc.xml","form_type":"4"}},{"id":2272478,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-05-13T19:13:16.000Z","date":"2022-05-12","kind":"sale","acquired":false,"shares":6450,"price":126.18,"value":813861.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $126.00 to $126.55. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":666060,"source":{"system":"sec-edgar","filing":"0001203311-22-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000035/edgardoc.xml","form_type":"4"}},{"id":2272477,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-05-13T19:13:16.000Z","date":"2022-05-12","kind":"exercise","acquired":true,"shares":6450,"price":26.1,"value":168345.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":672510,"source":{"system":"sec-edgar","filing":"0001203311-22-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000035/edgardoc.xml","form_type":"4"}},{"id":2279545,"issuer":{"id":1156,"kind":"organization","name":"Nurix Therapeutics, Inc.","symbol":"NRIX"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2022-05-06T21:43:06.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 5, 2023, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":10.39,"expiration_date":"2032-05-04","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-22-027668","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000120919122027668/doc4.xml","form_type":"4"}},{"id":2292041,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-04-22T20:34:28.000Z","date":"2022-04-20","kind":"sale","acquired":false,"shares":1885,"price":144.3186,"value":272040.561,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":666060,"source":{"system":"sec-edgar","filing":"0001203311-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000033/edgardoc.xml","form_type":"4"}},{"id":2300589,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"exercise","acquired":false,"shares":474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":68172,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":474},"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300588,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"exercise","acquired":false,"shares":1900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":68646,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":1900},"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300587,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"exercise","acquired":false,"shares":3828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":70546,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":3828},"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300586,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"exercise","acquired":false,"shares":2400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":74374,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":2400},"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300585,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"exercise","acquired":false,"shares":4692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":76774,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":4692},"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300584,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"exercise","acquired":false,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":81466,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":2100},"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300583,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"exercise","acquired":false,"shares":1649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":83566,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":1649},"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300582,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"sale","acquired":false,"shares":474,"price":157.23,"value":74527.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $157.17 to $157.28. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300581,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"exercise","acquired":true,"shares":474,"price":26.1,"value":12371.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":668419,"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300580,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"sale","acquired":false,"shares":1900,"price":156.48,"value":297312.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $156.15 to $157.10. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300579,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"exercise","acquired":true,"shares":1900,"price":26.1,"value":49590.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":669845,"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300578,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"sale","acquired":false,"shares":3828,"price":155.83,"value":596517.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $155.14 to $156.13. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300577,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"exercise","acquired":true,"shares":3828,"price":26.1,"value":99910.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":671773,"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300576,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"sale","acquired":false,"shares":2400,"price":154.36,"value":370464.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $154.03 to $154.97. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300575,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"exercise","acquired":true,"shares":2400,"price":26.1,"value":62640.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":670345,"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300574,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"sale","acquired":false,"shares":4692,"price":153.38,"value":719658.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $153.00 to $153.94. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300573,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"exercise","acquired":true,"shares":4692,"price":26.1,"value":122461.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":672637,"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300572,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"sale","acquired":false,"shares":2100,"price":152.59,"value":320439.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $151.98 to $152.92. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300571,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"exercise","acquired":true,"shares":2100,"price":26.1,"value":54810.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":670045,"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300570,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"sale","acquired":false,"shares":1649,"price":151.42,"value":249691.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $150.90 to $151.86. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2300569,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-08T21:41:30.000Z","date":"2022-04-07","kind":"exercise","acquired":true,"shares":1649,"price":26.1,"value":43038.9,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":669594,"source":{"system":"sec-edgar","filing":"0000899243-22-014397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000089924322014397/doc4.xml","form_type":"4"}},{"id":2342510,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-09T19:42:40.000Z","date":"2022-03-07","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":85215,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001203311-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000018/edgardoc.xml","form_type":"4"}},{"id":2342509,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-09T19:42:40.000Z","date":"2022-03-07","kind":"exercise","acquired":false,"shares":6643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":89215,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":6643},"source":{"system":"sec-edgar","filing":"0001203311-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000018/edgardoc.xml","form_type":"4"}},{"id":2342508,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-09T19:42:40.000Z","date":"2022-03-07","kind":"exercise","acquired":false,"shares":2400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":95858,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":2400},"source":{"system":"sec-edgar","filing":"0001203311-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000018/edgardoc.xml","form_type":"4"}},{"id":2342507,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-09T19:42:40.000Z","date":"2022-03-07","kind":"exercise","acquired":false,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":98258,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":3900},"source":{"system":"sec-edgar","filing":"0001203311-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000018/edgardoc.xml","form_type":"4"}},{"id":2342506,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-09T19:42:40.000Z","date":"2022-03-07","kind":"exercise","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":102158,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001203311-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000018/edgardoc.xml","form_type":"4"}},{"id":2342505,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-03-09T19:42:40.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":4000,"price":135.62,"value":542480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $135.28 to $136.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0001203311-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000018/edgardoc.xml","form_type":"4"}},{"id":2342504,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-03-09T19:42:40.000Z","date":"2022-03-07","kind":"exercise","acquired":true,"shares":4000,"price":26.1,"value":104400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":671945,"source":{"system":"sec-edgar","filing":"0001203311-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000018/edgardoc.xml","form_type":"4"}},{"id":2342503,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-03-09T19:42:40.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":6643,"price":134.74,"value":895077.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $134.26 to $135.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0001203311-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000018/edgardoc.xml","form_type":"4"}},{"id":2342502,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-03-09T19:42:40.000Z","date":"2022-03-07","kind":"exercise","acquired":true,"shares":6643,"price":26.1,"value":173382.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":674588,"source":{"system":"sec-edgar","filing":"0001203311-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000018/edgardoc.xml","form_type":"4"}},{"id":2342501,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-03-09T19:42:40.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":2400,"price":133.69,"value":320856.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $133.16 to $134.09. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0001203311-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000018/edgardoc.xml","form_type":"4"}},{"id":2342500,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-03-09T19:42:40.000Z","date":"2022-03-07","kind":"exercise","acquired":true,"shares":2400,"price":26.1,"value":62640.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":670345,"source":{"system":"sec-edgar","filing":"0001203311-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000018/edgardoc.xml","form_type":"4"}},{"id":2342499,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-03-09T19:42:40.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":3900,"price":132.72,"value":517608.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $132.15 to $133.14. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0001203311-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000018/edgardoc.xml","form_type":"4"}},{"id":2342498,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-03-09T19:42:40.000Z","date":"2022-03-07","kind":"exercise","acquired":true,"shares":3900,"price":26.1,"value":101790.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":671845,"source":{"system":"sec-edgar","filing":"0001203311-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000018/edgardoc.xml","form_type":"4"}},{"id":2342497,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-03-09T19:42:40.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":100,"price":136.33,"value":13633.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0001203311-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000018/edgardoc.xml","form_type":"4"}},{"id":2342496,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-03-09T19:42:40.000Z","date":"2022-03-07","kind":"exercise","acquired":true,"shares":100,"price":26.1,"value":2610.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":668045,"source":{"system":"sec-edgar","filing":"0001203311-22-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000018/edgardoc.xml","form_type":"4"}},{"id":2406847,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-02-09T19:02:45.000Z","date":"2022-02-07","kind":"exercise","acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":102258,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":300},"source":{"system":"sec-edgar","filing":"0001203311-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000014/edgardoc.xml","form_type":"4"}},{"id":2406846,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-02-09T19:02:45.000Z","date":"2022-02-07","kind":"exercise","acquired":false,"shares":4084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":102558,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":4084},"source":{"system":"sec-edgar","filing":"0001203311-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000014/edgardoc.xml","form_type":"4"}},{"id":2406845,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-02-09T19:02:45.000Z","date":"2022-02-07","kind":"exercise","acquired":false,"shares":8985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":106642,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":8985},"source":{"system":"sec-edgar","filing":"0001203311-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000014/edgardoc.xml","form_type":"4"}},{"id":2406844,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-02-09T19:02:45.000Z","date":"2022-02-07","kind":"exercise","acquired":false,"shares":3574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":115627,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":3574},"source":{"system":"sec-edgar","filing":"0001203311-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000014/edgardoc.xml","form_type":"4"}},{"id":2406843,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-02-09T19:02:45.000Z","date":"2022-02-07","kind":"exercise","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":119201,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001203311-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000014/edgardoc.xml","form_type":"4"}},{"id":2406842,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-09T19:02:45.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":300,"price":141.56,"value":42468.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $141.40 to $141.78. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0001203311-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000014/edgardoc.xml","form_type":"4"}},{"id":2406841,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-09T19:02:45.000Z","date":"2022-02-07","kind":"exercise","acquired":true,"shares":300,"price":26.1,"value":7830.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":668245,"source":{"system":"sec-edgar","filing":"0001203311-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000014/edgardoc.xml","form_type":"4"}},{"id":2406840,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-09T19:02:45.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":4084,"price":140.83,"value":575149.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $140.36 to $141.32. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0001203311-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000014/edgardoc.xml","form_type":"4"}},{"id":2406839,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-09T19:02:45.000Z","date":"2022-02-07","kind":"exercise","acquired":true,"shares":4084,"price":26.1,"value":106592.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":672029,"source":{"system":"sec-edgar","filing":"0001203311-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000014/edgardoc.xml","form_type":"4"}},{"id":2406838,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-09T19:02:45.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":8985,"price":139.96,"value":1257540.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $139.36 to $140.35. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0001203311-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000014/edgardoc.xml","form_type":"4"}},{"id":2406837,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-09T19:02:45.000Z","date":"2022-02-07","kind":"exercise","acquired":true,"shares":8985,"price":26.1,"value":234508.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":676930,"source":{"system":"sec-edgar","filing":"0001203311-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000014/edgardoc.xml","form_type":"4"}},{"id":2406836,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-09T19:02:45.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":3574,"price":138.97,"value":496678.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $138.36 to $139.35. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0001203311-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000014/edgardoc.xml","form_type":"4"}},{"id":2406835,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-09T19:02:45.000Z","date":"2022-02-07","kind":"exercise","acquired":true,"shares":3574,"price":26.1,"value":93281.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":671519,"source":{"system":"sec-edgar","filing":"0001203311-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000014/edgardoc.xml","form_type":"4"}},{"id":2406834,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-09T19:02:45.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":100,"price":137.29,"value":13729.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0001203311-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000014/edgardoc.xml","form_type":"4"}},{"id":2406833,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-09T19:02:45.000Z","date":"2022-02-07","kind":"exercise","acquired":true,"shares":100,"price":26.1,"value":2610.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":668045,"source":{"system":"sec-edgar","filing":"0001203311-22-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000014/edgardoc.xml","form_type":"4"}},{"id":2438133,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-01-11T19:14:52.000Z","date":"2022-01-07","kind":"exercise","acquired":false,"shares":8163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":119301,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":8163},"source":{"system":"sec-edgar","filing":"0001203311-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000004/edgardoc.xml","form_type":"4"}},{"id":2438132,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-01-11T19:14:52.000Z","date":"2022-01-07","kind":"exercise","acquired":false,"shares":4560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":127464,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":4560},"source":{"system":"sec-edgar","filing":"0001203311-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000004/edgardoc.xml","form_type":"4"}},{"id":2438131,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-01-11T19:14:52.000Z","date":"2022-01-07","kind":"exercise","acquired":false,"shares":3221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":132024,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":3221},"source":{"system":"sec-edgar","filing":"0001203311-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000004/edgardoc.xml","form_type":"4"}},{"id":2438130,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-01-11T19:14:52.000Z","date":"2022-01-07","kind":"exercise","acquired":false,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16."}],"balance_after":135245,"derivative":{"exercise_price":26.1,"expiration_date":"2022-08-20","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001203311-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000004/edgardoc.xml","form_type":"4"}},{"id":2438129,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-11T19:14:52.000Z","date":"2022-01-07","kind":"sale","acquired":false,"shares":8163,"price":143.91,"value":1174737.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $143.41 to $144.38. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0001203311-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000004/edgardoc.xml","form_type":"4"}},{"id":2438128,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-11T19:14:52.000Z","date":"2022-01-07","kind":"exercise","acquired":true,"shares":8163,"price":26.1,"value":213054.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":676108,"source":{"system":"sec-edgar","filing":"0001203311-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000004/edgardoc.xml","form_type":"4"}},{"id":2438127,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-11T19:14:52.000Z","date":"2022-01-07","kind":"sale","acquired":false,"shares":4560,"price":144.82,"value":660379.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $144.41 to $145.36. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0001203311-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000004/edgardoc.xml","form_type":"4"}},{"id":2438126,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-11T19:14:52.000Z","date":"2022-01-07","kind":"exercise","acquired":true,"shares":4560,"price":26.1,"value":119016.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":672505,"source":{"system":"sec-edgar","filing":"0001203311-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000004/edgardoc.xml","form_type":"4"}},{"id":2438125,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-11T19:14:52.000Z","date":"2022-01-07","kind":"sale","acquired":false,"shares":3221,"price":145.84,"value":469750.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of common stock executed in multiple transactions at prices ranging from $145.42 to $146.38. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":667945,"source":{"system":"sec-edgar","filing":"0001203311-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000004/edgardoc.xml","form_type":"4"}},{"id":2438124,"issuer":{"id":13956,"kind":"organization","name":"Seagen Inc.","symbol":"SGEN"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-01-11T19:14:52.000Z","date":"2022-01-07","kind":"exercise","acquired":true,"shares":3221,"price":26.1,"value":84068.1,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting."}],"balance_after":671166,"source":{"system":"sec-edgar","filing":"0001203311-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1060736/000120331122000004/edgardoc.xml","form_type":"4"}}],"next_cursor":"2022-01-11T19:14:52.000000Z,2438124"}